Insider trades: There are dozens of insider trades made each week, and reported to the SEC, which are then made public. Let’s take a look at seven of the most important you should be paying attention to.
Katherine Anderson, Chief Financial Officer at Repros Therapeutics Inc (NASDAQ:RPRX), bought 1,000 shares. The move came amid safety and efficiency reports from Repros about its new drug, Androxal, which is being developed for testosterone development in men.
KB Home (NYSE:KBH) was also in the middle of two insider transactions recently. Thomas S Silk, SVP of Marketing and Communications, acquired 5,000 shares of common stock, at a price of $6.04 apiece, with the value of the deal amounting to $30,200. Jeffrey T. Mezger, President and CEO at KB Home, bought 150,000 shares, and Jeff Kaminski, EVP & Chief Financial Officer, acquired 15,000 shares.
John A. Crum, Chairman, President and CEO of Midstates Petroleum Company Inc (NYSE:MPO), increased his position in the company by 10,000 shares, to 1.3 million total.
J Michael Ancius, Director at Fastenal Company (NASDAQ:FAST), now holds 6,600 shares, worth $317,130. The trades were made at a price of $47.91 per share.
A director at Century Bancorp, Inc. (NASDAQ:CNBKA), Marshall M. Sloane, bought 304 shares, increasing his holdings slightly.
Markel Corporation (NYSE:MKL)’s director, D Darrell Martin, bought 150 shares at a price of $538.30 a pop.
Three insiders at Occidental Petroleum bought in: VP James Lienert, VP Edward Lowe and VP Controller Pineci Roy.